Caribou Biosciences, Inc. (CRBU) Shareholders’ equity 2019–2025
Caribou Biosciences, Inc. (CRBU) shareholders’ equity at each fiscal year-end, per SEC filings.
$122.2MFY2025 · since FY2019: $7.5M → $122.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $122.2M | -51.7% |
| FY2024 | $253.0M | -31.3% |
| FY2023 | $368.4M | +22.4% |
| FY2022 | $300.9M | -22.4% |
| FY2021 | $387.8M | +1754.8% |
| FY2020 | -$23.4M | -414.0% |
| FY2019 | $7.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice